Page last updated: 2024-09-02

tadalafil and Right Ventricular Dysfunction

tadalafil has been researched along with Right Ventricular Dysfunction in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chin, K; Damico, R; Girgis, RE; Hassoun, PM; Khair, RM; Kolb, TM; Mathai, SC; Mercurio, V; Minai, OA; Mukherjee, M; Sato, T; Tedford, RJ; Torres, F; Zamanian, RT	1
Miyasaka, A; Morino, Y; Suzuki, A; Takikawa, Y; Ueda, H; Yoshida, Y	1
Akers, S; Ambrosini, R; Champion, HC; Glickman, S; Haight, D; Lachant, DJ; Meoli, DF; Staicu, S; White, RJ	1

Trials

1 trial(s) available for tadalafil and Right Ventricular Dysfunction

Article	Year
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. American journal of respiratory and critical care medicine, 2018, 02-01, Volume: 197, Issue:3 Topics: Aged; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Observer Variation; Phenylpropionates; Prospective Studies; Pyridazines; Scleroderma, Limited; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Right	2018

Article

Year

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine, 2018, 02-01, Volume: 197, Issue:3

Topics: Aged; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Observer Variation; Phenylpropionates; Prospective Studies; Pyridazines; Scleroderma, Limited; Tadalafil; Treatment Outcome; Ventricular Dysfunction, Right

2018

Other Studies

2 other study(ies) available for tadalafil and Right Ventricular Dysfunction

Article	Year
A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:1 Topics: Adult; Antiviral Agents; Cardiac Catheterization; Echocardiography; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Liver Cirrhosis; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pyrimidines; Sulfonamides; Sustained Virologic Response; Tadalafil; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Right	2020
Combination therapy improves vascular volume in female rats with pulmonary hypertension. American journal of physiology. Lung cellular and molecular physiology, 2019, 10-01, Volume: 317, Issue:4 Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Phenylpropionates; Pneumonectomy; Pulmonary Artery; Pyridazines; Rats; Rats, Sprague-Dawley; Tadalafil; Vascular Remodeling; Vasoconstriction; Ventricular Dysfunction, Right; X-Ray Microtomography	2019

Article

Year

A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection.

Clinical journal of gastroenterology, 2020, Volume: 13, Issue:1

Topics: Adult; Antiviral Agents; Cardiac Catheterization; Echocardiography; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Liver Cirrhosis; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pyrimidines; Sulfonamides; Sustained Virologic Response; Tadalafil; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Right

2020

Combination therapy improves vascular volume in female rats with pulmonary hypertension.

American journal of physiology. Lung cellular and molecular physiology, 2019, 10-01, Volume: 317, Issue:4

Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Phenylpropionates; Pneumonectomy; Pulmonary Artery; Pyridazines; Rats; Rats, Sprague-Dawley; Tadalafil; Vascular Remodeling; Vasoconstriction; Ventricular Dysfunction, Right; X-Ray Microtomography

2019